Suchergebnisse - "Claxton, David"

PubPharm (206)

21

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

enthalten in: Annals of hematology | 2022

von Cioccio, J. | Rakszawski, K. | Zheng, H. | +16

22

Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide

enthalten in: Leukemia research | 2022

von Shah, N. | Cioccio, J. | Rakszawski, K. | +18

23

Subtype-specific 3D genome alteration in acute myeloid leukaemia

enthalten in: Nature | 2022

von Xu, J. | Song, F. | Lyu, H. | +26

24

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

enthalten in: Bone marrow transplantation | 2022

von Pizzola, C. | Cioccio, J. | Rakszawski, K. | +12

25

Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2022

von Khokhlatchev, A. | Sharma, A. | Deering, T. | +13

26

Harnessing the power of sphingolipids : Prospects for acute myeloid leukemia

enthalten in: Blood reviews | 2022

von Ung, J. | Tan, S. | Fox, T. | +13

27

Alterations in Sphingolipid Composition and Mitochondrial Complex I Deficiency Represent Synergistic Therapeutic Vulnerabilities Linked to Vincristine Resistance

enthalten in: ResearchSquare.com | 2022

von Fisher-Wellman, K. | Hagen, J. | Kassai, M. | +11

28

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

enthalten in: ResearchSquare.com | 2022

von Fisher-Wellman, K. | Hagen, J. | Kassai, M. | +11

29

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

enthalten in: ResearchSquare.com | 2022

von Fisher-Wellman, K. | Hagen, J. | Kassai, M. | +11

30

NPM1 mutation mediated HOXBLINC lncRNA activation promotes AML leukemogenesis

enthalten in: ResearchSquare.com | 2022

von Zhu, G. | Luo, H. | Feng, Y. | +15